New combo therapy aims to fight prostate cancer while preserving sexual function
NCT ID NCT04025372
First seen Jan 04, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This study tests whether a newer hormone drug (darolutamide) combined with radiation works as well as standard hormone therapy for intermediate-risk prostate cancer, but with fewer side effects on erections. About 234 men will take part. The goal is to control the cancer while helping men maintain erectile function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Associated Medical Professionals of NY
Syracuse, New York, 13210, United States
-
Beth Israel Deaconness Medical Center
Boston, Massachusetts, 02115, United States
-
Brigham and Women Hospital
Boston, Massachusetts, 02115, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
Milford, Massachusetts, 01757, United States
-
Dana-Farber/Brigham and Women's Cancer Center in Clinical Affiliation with South Shore Hospital
South Weymouth, Massachusetts, 02190, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
NYU Long Island
Garden City, New York, 11530, United States
-
Stamford Hospital
Stamford, Connecticut, 06904, United States
-
Washington University School of Medicine in St. Louis
St Louis, Missouri, 63108, United States
-
XCancer Omaha / Urology Cancer Center
Omaha, Nebraska, 68130, United States
Conditions
Explore the condition pages connected to this study.